Mirum Pharmaceuticals's total assets for Q1 2026 were $890.92M, an increase of 5.71% from the previous quarter. MIRM total liabilities were $648.42M for the fiscal quarter, a 22.78% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.